HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ricardo Sobhie Diaz Selected Research

Pharmaceutical Preparations

1/2022The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.
7/2021Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.
1/2014Analysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, Brazil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ricardo Sobhie Diaz Research Topics

Disease

15Infections
07/2021 - 08/2003
5COVID-19
01/2022 - 01/2021
5Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 09/2006
4HIV Infections (HIV Infection)
11/2019 - 07/2014
3Disease Progression
01/2022 - 08/2003
2Viremia
11/2019 - 01/2011
2Inflammation (Inflammations)
01/2019 - 09/2017
2Hepatitis B
02/2017 - 11/2014
1Respiratory Insufficiency (Respiratory Failure)
07/2021
1Shock
01/2021
1Neoplasms (Cancer)
05/2019
1Autoimmune Diseases (Autoimmune Disease)
05/2019
1Coinfection
10/2017
1Retroviridae Infections (Infection, Retrovirus)
02/2011
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2009
1Carcinoma (Carcinomatosis)
06/2009
1HIV Seropositivity
02/2007
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
11/2005

Drug/Important Bio-Agent (IBA)

5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2005
3Antiviral Agents (Antivirals)IBA
01/2022 - 02/2017
3Pharmaceutical PreparationsIBA
01/2022 - 01/2014
2nitazoxanide (NTZ)FDA Link
11/2021 - 07/2021
2Peptide Hydrolases (Proteases)FDA Link
01/2020 - 01/2014
2Proteins (Proteins, Gene)FDA Link
05/2019 - 02/2011
2EnzymesIBA
07/2014 - 02/2007
1CobicistatIBA
01/2022
1Carbon Nanotubes (Carbon Nanotube)IBA
01/2022
1remdesivirIBA
01/2022
1AntibodiesIBA
07/2021
1Immunoglobulin M (IgM)IBA
07/2021
1Immunoglobulin G (IgG)IBA
07/2021
1OrnithineIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1AcidsIBA
01/2021
1Urea (Carbamide)FDA LinkGeneric
01/2021
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2021
1CitrullineIBA
01/2021
1serum P-component (CIt)IBA
01/2021
1Tryptophan (L-Tryptophan)FDA Link
01/2021
1KynurenineIBA
01/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1CytokinesIBA
11/2019
1DEET (DET)IBA
11/2019
1PhytohemagglutininsIBA
11/2019
1SuspensionsIBA
11/2019
1interleukin-24 (ST16)IBA
05/2019
1Aurora Kinase CIBA
10/2018
1Aurora Kinase BIBA
10/2018
1DNA Methyltransferase 3BIBA
10/2018
1Thalidomide (Thalomid)FDA Link
09/2017
1AntigensIBA
01/2017
1Protease Inhibitors (Protease Inhibitor)IBA
11/2015
1Reverse Transcriptase InhibitorsIBA
11/2015
12,5-dichloro-4-bromophenol (B 2)IBA
11/2015
1NucleosidesIBA
11/2015
1HLA-C Antigens (HLA-C)IBA
11/2014
1Human immunodeficiency virus 1 p16 proteaseIBA
01/2014
1Viral DNAIBA
02/2011
1BilirubinIBA
06/2009
1VaccinesIBA
09/2006
1Isoleucine (L-Isoleucine)FDA Link
08/2003
1Valine (L-Valine)FDA Link
08/2003

Therapy/Procedure

7Therapeutics
01/2022 - 02/2007
3Art Therapy
11/2019 - 01/2019
3Highly Active Antiretroviral Therapy (HAART)
01/2017 - 01/2011
1Immunotherapy
01/2022
1Blood Transfusion (Blood Transfusions)
01/2012